Skip to content

Mingshi Granule in the treatment of children's low-grade myopia progression: a multi-center, double-blind, double-simulation, randomized controlled trial

Mingshi Granule in the treatment of children's low-grade myopia progression: a multi-center, double-blind, double-simulation, randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039297
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Control group :Health education + optometry + placebo

Sponsors

Ophthalmic Hospital of Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Subject of equivalent spherical mirror power: - 3.00ds <= se < - 0.50ds; 2. Subjects aged 7-12 years; 3. TCM syndrome: deficiency of heart Yang; 4. The subject of informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other eye diseases that affect vision; 2. Patients with serious systemic diseases; 3. Strabismus and amblyopia; 4. Both parents or one of them has high myopia in one eye or both eyes (equivalent spherical lens < - 6.00ds); 5. Subjects who are using other methods or participating in other research.

Design outcomes

Primary

MeasureTime frame
spherical equivalent;TCM syndrom score;

Secondary

MeasureTime frame
Best distance vision with naked eyes;Eye axis;Corneal curvature;Adjustment range;

Countries

China

Contacts

Public ContactZefeng Kang

Ophthalmic Hospital of Chinese Academy of Traditional Chinese Medicine

zefeng2531@163.com+86 13552597717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026